DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,962,967 | +29.6% | 7,912 | +25.3% | 0.43% | +57.8% |
| Q2 2023 | $1,514,880 | -24.0% | 6,312 | -20.2% | 0.28% | -49.9% |
| Q1 2023 | $1,994,140 | -7.6% | 7,912 | -2.7% | 0.55% | +13.9% |
| Q4 2022 | $2,158,395 | +0.4% | 8,132 | -2.3% | 0.48% | -33.3% |
| Q3 2022 | $2,149,000 | +2.8% | 8,322 | +0.9% | 0.72% | +54.8% |
| Q2 2022 | $2,090,000 | -25.8% | 8,245 | -14.2% | 0.47% | +15.0% |
| Q1 2022 | $2,818,000 | -87.9% | 9,606 | -86.4% | 0.41% | -87.1% |
| Q4 2021 | $23,311,000 | +3.9% | 70,852 | -3.9% | 3.14% | -2.1% |
| Q3 2021 | $22,439,000 | +14.0% | 73,706 | +0.5% | 3.20% | +21.1% |
| Q2 2021 | $19,679,000 | +472.7% | 73,332 | +380.4% | 2.65% | +435.8% |
| Q1 2021 | $3,436,000 | -5.8% | 15,265 | -7.0% | 0.49% | -2.2% |
| Q4 2020 | $3,647,000 | +4.4% | 16,417 | +1.2% | 0.50% | -16.8% |
| Q3 2020 | $3,494,000 | +17.2% | 16,227 | -3.8% | 0.61% | +19.7% |
| Q2 2020 | $2,981,000 | +19.5% | 16,860 | -6.5% | 0.51% | -23.4% |
| Q1 2020 | $2,495,000 | -11.3% | 18,025 | -1.6% | 0.66% | +66.8% |
| Q4 2019 | $2,812,000 | +6.1% | 18,320 | -0.2% | 0.40% | -7.5% |
| Q3 2019 | $2,651,000 | +1.0% | 18,357 | 0.0% | 0.43% | -9.5% |
| Q2 2019 | $2,624,000 | +6.5% | 18,357 | -1.6% | 0.47% | -1.7% |
| Q1 2019 | $2,463,000 | -13.0% | 18,657 | -32.0% | 0.48% | -31.3% |
| Q4 2018 | $2,830,000 | -27.1% | 27,447 | -23.2% | 0.70% | +14.3% |
| Q3 2018 | $3,882,000 | +10.2% | 35,730 | +0.1% | 0.61% | -4.8% |
| Q2 2018 | $3,523,000 | +2.7% | 35,700 | +1.9% | 0.64% | -6.8% |
| Q1 2018 | $3,431,000 | -83.1% | 35,044 | -84.0% | 0.69% | -75.4% |
| Q4 2017 | $20,334,000 | +24.7% | 219,070 | +15.2% | 2.81% | +1.0% |
| Q3 2017 | $16,307,000 | -20.5% | 190,100 | -21.8% | 2.78% | -22.3% |
| Q2 2017 | $20,516,000 | -0.2% | 243,108 | +1.1% | 3.58% | -12.1% |
| Q1 2017 | $20,562,000 | +9.8% | 240,402 | -0.0% | 4.07% | +26.5% |
| Q4 2016 | $18,720,000 | -3.2% | 240,492 | -2.5% | 3.22% | -18.3% |
| Q3 2016 | $19,336,000 | -22.5% | 246,665 | -0.2% | 3.94% | -26.4% |
| Q2 2016 | $24,961,000 | +5.6% | 247,143 | -0.8% | 5.35% | -12.1% |
| Q1 2016 | $23,630,000 | +43.6% | 249,101 | +40.6% | 6.09% | +56.0% |
| Q4 2015 | $16,458,000 | +3.7% | 177,199 | -4.8% | 3.90% | +1.3% |
| Q3 2015 | $15,869,000 | -37.6% | 186,229 | -37.3% | 3.85% | -24.0% |
| Q2 2015 | $25,424,000 | -4.8% | 297,049 | -5.6% | 5.06% | -4.7% |
| Q1 2015 | $26,713,000 | -2.6% | 314,640 | -1.7% | 5.32% | +11.9% |
| Q4 2014 | $27,423,000 | +12.6% | 319,950 | -0.2% | 4.75% | +7.2% |
| Q3 2014 | $24,349,000 | -4.7% | 320,464 | -1.2% | 4.43% | +2.7% |
| Q2 2014 | $25,542,000 | +6.4% | 324,429 | +1.4% | 4.31% | -0.4% |
| Q1 2014 | $23,997,000 | -3.7% | 319,955 | -0.9% | 4.33% | -6.4% |
| Q4 2013 | $24,921,000 | +8.0% | 322,807 | -3.0% | 4.63% | -0.0% |
| Q3 2013 | $23,079,000 | +34.0% | 332,935 | +22.4% | 4.63% | +17.5% |
| Q2 2013 | $17,220,000 | – | 272,038 | – | 3.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |